Purchase Order 75N93022P00393

Award Date 3/11/22
Potential Completion Date 3/10/27
Potential Value $206K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...
This federal contract award, valued at $73,050.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., a for-profit organization specializing in organ-on-a-chip technology. The award is for a Restricted Lab Service Program to provide four Zoe CM2 Culture Modules for Organ Chips. The contract is a Firm Fixed Price Purchase Order with a completion date of September 16, 2025. This award does not utilize a set-aside designation. Emulate Inc., also known...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Emulate Inc., a for-profit small business. The contract, valued at $145,260.00, is for the delivery of Emulate's CHIP-S1 Stretchable Chip, a product in their organ-on-a-chip technology line. This technology supports various FDA and HHS initiatives in areas such as personalized medicine, biosurveillance, infectious disease...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Emulate Inc., a for-profit small business organization. The contract, valued at $24,997.00, is for the delivery of biological kits and reagents, which are likely components of Emulate's organ-on-a-chip technology products used to model human biology. These products support the National Cancer Institute's initiatives in areas such as...
This federal contract award, valued at $75,000.00, was issued by the Uniformed Services University of the Health Sciences, a defense agency, to Emulate Inc. (doing business as Emulate), a biotechnology company specializing in organ-on-chip technology. The contract is for the delivery of 3-dimensional organ-on-chip technology to support the agency's research initiatives. This is a firm fixed-price purchase order contract with an ultimate completion date of August 31, 2020. The contract was not...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Emulate Inc. (doing business as Emulate) for a "Service Agreement for Zoe". The contract has a ceiling value of $19,096.00 and a period of performance through May 30, 2026. It was awarded on May 31, 2024 and was not set aside for any specific business category. Emulate is a biotechnology...
This is a federal purchase order contract awarded by the Uniformed Services University of the Health Sciences, a defense agency, to Emulate Inc. for a micro engineered biometric system that represents key functional units of living human organs. The firm fixed price contract, with a ceiling value of $86,600.00, was awarded on February 19, 2021 and has an ultimate completion date of April 1, 2021. Emulate Inc., a for-profit biotechnology company based in Boston, Massachusetts, specializes in...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,616 purchase order to Emulate Inc., doing business as Emulate, located in Rockville, Maryland. The contract is for a one-year period starting December 20, 2023 through December 19, 2024 to provide a complete human emulation system as a service. No subcontractors or set aside designations were identified. The National Cancer Institute supports research to advance cancer prevention,...
This is a federal contract award from the U.S. Army Research, Development and Engineering Command (RDECOM) to Emulate Inc., a biotechnology company specializing in organ-on-chip technology. The $82,750.02 firm fixed-price purchase order is for the delivery of "LIVER HEALTHY QUAD #CULTURE KITS." Emulate, a for-profit organization based in Boston, Massachusetts, has a history of supplying advanced microphysiological systems and associated services to various federal agencies, primarily...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract, valued at $205,554.00, is for an extended warranty and service agreement for Emulate's organ-on-a-chip technology, which models human biology for biomedical research. This requirement supports NIAID's Integrated Research Facility (IRF-Frederick) mission to facilitate research on Risk Group 4 pathogens and improve patient outcomes. There is no small business set-aside for this full and open competition contract. Emulate has previously received prime federal awards, including from the Defense Advanced Research Projects Agency (DARPA), to support initiatives in areas like personalized medicine, biosurveillance, and alternatives to animal testing.

Generated 3/22/24, 7:50 PM